Understanding how oxygen levels affect tendon healing and development
Regulation of Tendon Enthesis Development and Healing via HIF1
This study is looking at how a special protein called HIF1a helps the Achilles tendon heal better, especially where it connects to the bone, and it aims to find ways to improve recovery after tendon injuries by understanding how low oxygen levels affect healing.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11061223 on NIH RePORTER |
What this research studies
This research investigates the role of Hypoxia Inducible Factor-1a (HIF1a) in the healing and development of the Achilles tendon, particularly focusing on the tendon-bone connection known as the enthesis. By studying how low oxygen levels influence cell survival and extracellular matrix production, the research aims to uncover mechanisms that could improve tendon repair after injury. The approach involves using advanced 3D cell culture techniques to mimic the conditions of tendon healing and assess the effects of HIF1a on cell behavior and tissue regeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have experienced Achilles tendon injuries or ruptures.
Not a fit: Patients with non-Achilles tendon injuries or those who are not experiencing tendon-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance tendon healing and reduce the risk of re-injury for patients with Achilles tendon injuries.
How similar studies have performed: Previous research has shown promising results in understanding the role of HIF1a in tissue regeneration, suggesting that this approach could lead to significant advancements in tendon healing.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Killian, Megan L. — University of Michigan at Ann Arbor
- Study coordinator: Killian, Megan L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.